Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Merck to buy drug developer Immune Design for $300 million

      Merck to buy drug developer Immune Design for $300 million

      Garima22 Feb 2019 10:05 AM IST
      Merck will pay $5.85 in cash for each share of Immune Design. Shares of Immune Design closed at $1.42 on Wednesday.U.S: Merck & Co Inc said on...
      AstraZeneca joins hands with NASSCOM to address burden of NCDs in India

      AstraZeneca joins hands with NASSCOM to address burden of NCDs in India

      Garima21 Feb 2019 5:14 PM IST
      New Delhi: In a move to set up an accelerator programme to reinforce Indian healthcare start-ups, biopharmaceutical major AstraZeneca and IT industry...
      Abbott, Novo Nordisk enters partnership to provide digital solution for diabetes management

      Abbott, Novo Nordisk enters partnership to provide digital solution for diabetes management

      Garima21 Feb 2019 9:30 AM IST
      The partnership reflects Abbott and Nordisk's commitment to make diabetes management easier by connecting key technologies such as continuous glucose...
      U.S. health spending to hit $6 trillion by 2027- CMS

      U.S. health spending to hit $6 trillion by 2027- CMS

      Garima21 Feb 2019 9:00 AM IST
      Rising income levels, better employment rate and more people enrolling for Medicare, the federal health insurance program for people aged 65 and above...
      Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

      Cipla to acquire 11.71 percent stake in Wellthy Therapeutics

      Garima20 Feb 2019 2:55 PM IST
      New Delhi: Drug major Cipla Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Golden cross Pharma, a...
      KKR to infuse up to Rs 300 crore in Baby Memorial Hospital in Kerala

      KKR to infuse up to Rs 300 crore in Baby Memorial Hospital in Kerala

      Garima19 Feb 2019 4:14 PM IST
      Baby Memorial Hospital is expected to use the funds provided by KKR to settle some debt and expand facilities besides financing some inorganic growth...
      Cipla, Wellthy Therapeutics enters partnership to offer Digital Therapeutics for Diabetes and CVDs

      Cipla, Wellthy Therapeutics enters partnership to offer Digital Therapeutics for Diabetes and CVDs

      Garima19 Feb 2019 9:25 AM IST
      Under the agreement, a multi-lingual clinically-validated digital disease management platform will be made available to patients living with diabetes...
      Bharat Biotech acquires GSK Indian arm that produces anti rabies vaccine

      Bharat Biotech acquires GSK Indian arm that produces anti rabies vaccine

      Garima18 Feb 2019 2:07 PM IST
      Hyderabad: Bharat Biotech has recently announced the forthcoming acquisition of Chiron Behring Vaccines Pvt Ltd, located in Ankleshwar, Gujarat from...
      TPG-Manipal enter into Exclusive talks to Acquire Medanta- Report

      TPG-Manipal enter into Exclusive talks to Acquire Medanta- Report

      Garima17 Feb 2019 10:05 AM IST
      Mumbai: After losing out on the Fortis deal, the Manipal Group backed by TPG is making moves toward acquiring Gurugram Based Medanta Medicity by...
      KKR to infuse Rs 2000 crore in Emami Group

      KKR to infuse Rs 2000 crore in Emami Group

      Garima17 Feb 2019 10:00 AM IST
      Mumbai: Headquartered in Kolkata, the Emami Group is all set to get fresh funds for its trade as the firm is in advanced negotiations with US private...
      Bayer stresses drugs tolerability in bid for prostate cancer market

      Bayer stresses drugs tolerability in bid for prostate cancer market

      Garima17 Feb 2019 9:05 AM IST
      Bayer is in discussions with regulators about a request for marketing approval and estimates annual peak sales of at least 1 billion euros ($1.13...
      GSK Consumer profit rises 35 percent to Rs 221.06 crore in December quarter

      GSK Consumer profit rises 35 percent to Rs 221.06 crore in December quarter

      Garima16 Feb 2019 9:20 AM IST
      "The merger is now subject to the receipt of other necessary statutory and regulatory approvals under applicable laws. The merger process is moving...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok